New York governor sees 'return to normalcy' with rapid coronavirus testing [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
New York governor sees 'return to normalcy' with rapid coronavirus testing (Reuters) - New York Governor Andrew Cuomo said on Sunday he believed there needed to be a mass rollout of rapid testing in order to achieve a “return to normalcy” after the peak of the novel coronavirus crisis passes in the United States in the coming weeks and months. Cuomo, whose state is the epicenter of the outbreak in the United States, said New York was part of an effort to develop a program that would identify people who are both negative and not in a vulnerable category, allowing them to go back to work. “I think you see the return to normalcy when we have an approved rapid testing program that can be brought to scale, Cuomo told a daily briefing on the coronavirus response. “That is going to be the answer, I believe.” New York, the hardest-hit state, reported on Sunday that there were nearly 600 new deaths for a total of 4,159 deaths and 122,000 total cases. Across the United States over 321,000 peopl
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $130.00 price target on the stock.MarketBeat
- Pregnancy Detection Kits Industry Report 2024, Featuring Key Players Alere, Church & Dwight, Confirm BioSciences, CVS Health, Mankind Pharma, Philippine Blue Cross Biotech, Prestige Brands and Quidel [Yahoo! Finance]Yahoo! Finance
- Guidewires Market to grow by USD 807 Million from 2024-2028, driven by rising chronic disorders, AI-powered report highlights impact on market trends - Technavio [Yahoo! Finance]Yahoo! Finance
- Global Drug Device Combination Products Market is expected to reach revenue of USD 389.7 Bn by 2033, at 9.3% CAGR: Dimension Market Research. [Yahoo! Finance]Yahoo! Finance
- Organic Baby Formula Market to Reach $17.7 Billion, Globally, by 2033 at 9.5% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- ABT's page on the SEC website